2,000
Participants
Start Date
November 1, 2025
Primary Completion Date
April 1, 2026
Study Completion Date
September 1, 2026
Aptitude Medical Systems Respiratory Panel Test
The Metrix Respiratory Panel Test is a real-time reverse transcription loop-mediated isothermal amplification reaction (RT-LAMP) test that has been designed to detect viral RNA from SARS-CoV-2, Influenza A, Influenza B, Respiratory Syncytial Virus, and Rhinovirus via electrochemical detection using the Metrix Reader. Detection of SARS-CoV-2, Influenza A, Influenza B, Respiratory Syncytial Virus, and Rhinovirus gene targets will produce a positive result, differentiated by each target. If no target is detected and the internal control amplifies, the result is negative. If no amplification is detected in any of the channels, an invalid result is displayed.
AFC Trussville, Trussville
Lead Sponsor
Aptitude Medical Systems
INDUSTRY